Search

Displaying results 2971 - 2980 of 4188 in total
  1. Drug

    Lodenafil carbonate

    go.drugbank.com/drugs/DB11927
    Investigational

    Lodenafil carbonate has been used in trials studying the treatment of Coronaropathy and Erectile Dysfunction.

  2. Drug

    AZD-4818

    go.drugbank.com/drugs/DB12002
    Investigational

    AZD4818 has been used in trials studying the treatment of Chronic Obstructive Pulmonary Disease (COPD).

  3. Drug

    Fosdagrocorat

    go.drugbank.com/drugs/DB12198
    Investigational

    Fosdagrocorat has been used in trials studying the treatment and basic science of Rheumatoid Arthritis.

  4. Drug

    Begacestat

    go.drugbank.com/drugs/DB12263
    Investigational

    Begacestat has been used in trials studying the treatment and basic science of Alzheimer Disease.

  5. Drug

    Edicotinib

    go.drugbank.com/drugs/DB12504
    Investigational

    JNJ-40346527 has been used in trials studying the treatment of Health and Arthritis, Rheumatoid.

  6. Drug

    AZD-9056

    go.drugbank.com/drugs/DB12594
    Investigational

    AZD9056 has been used in trials studying the basic science and treatment of Rheumatoid Arthritis.

  7. Drug

    Gadopentetic acid

    go.drugbank.com/drugs/DB00789
    ApprovedInvestigational

    A complex of gadolinium with a chelating agent, diethylenetriamine penta-acetic acid (DTPA see pentetic acid), that is given to enhance the image in cranial and spinal MRIs. (From Martindale, The Extra Pharmacopoeia, 30th ed, p706)

  8. Drug

    Azficel-T

    go.drugbank.com/drugs/DB11051
    ApprovedWithdrawn

    Azficel-T is an autologous cellular product composed of fibroblasts indicated for improvement of the appearance of moderate to severe nasolabial fold wrinkles in adults. Dermal fibroblasts are collected from the post-auricular biopsy tis...

  9. Drug

    Chromic nitrate

    go.drugbank.com/drugs/DB14527
    Approved

  10. Drug

    Dupilumab

    go.drugbank.com/drugs/DB12159
    ApprovedInvestigational

    Dupilumab is a fully human monoclonal antibody of the immunoglobulin G4 subclass that binds to the interleukin-4 (IL-4) receptor, inhibiting the receptor signaling pathways. As an interleukin-4 receptor alpha antagonist, dupilumab inhibi...